These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 2893251)
1. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog. Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251 [TBL] [Abstract][Full Text] [Related]
2. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells. Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823 [TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein-independent mechanism of resistance to VP-16 in multidrug-resistant tumor cell lines: pharmacokinetic and photoaffinity labeling studies. Politi PM; Arnold ST; Felsted RL; Sinha BK Mol Pharmacol; 1990 Jun; 37(6):790-6. PubMed ID: 1972771 [TBL] [Abstract][Full Text] [Related]
4. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine. Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941 [TBL] [Abstract][Full Text] [Related]
5. Analysis of structural features of dihydropyridine analogs needed to reverse multidrug resistance and to inhibit photoaffinity labeling of P-glycoprotein. Nogae I; Kohno K; Kikuchi J; Kuwano M; Akiyama S; Kiue A; Suzuki K; Yoshida Y; Cornwell MM; Pastan I Biochem Pharmacol; 1989 Feb; 38(3):519-27. PubMed ID: 2563655 [TBL] [Abstract][Full Text] [Related]
6. Correlation between reversing of multidrug resistance and inhibiting of [3H]azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Kamiwatari M; Nagata Y; Kikuchi H; Yoshimura A; Sumizawa T; Shudo N; Sakoda R; Seto K; Akiyama S Cancer Res; 1989 Jun; 49(12):3190-5. PubMed ID: 2566378 [TBL] [Abstract][Full Text] [Related]
7. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells. Nare B; Prichard RK; Georges E Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815 [TBL] [Abstract][Full Text] [Related]
8. N-ethylmaleimide increases P-glycoprotein photoaffinity labeling with iodoaryl-azidoprazosin in multidrug resistant cells. Wang Y; Georges E Anticancer Res; 1997; 17(1A):357-64. PubMed ID: 9066677 [TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance in Yoshida rat ascites hepatoma cell lines. Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121 [TBL] [Abstract][Full Text] [Related]
10. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells. Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532 [TBL] [Abstract][Full Text] [Related]
11. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells. Safa AR; Agresti M; Bryk D; Tamai I Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen aziridine, a novel affinity probe for P-glycoprotein in multidrug resistant cells. Safa AR; Roberts S; Agresti M; Fine RL Biochem Biophys Res Commun; 1994 Jul; 202(1):606-12. PubMed ID: 7913604 [TBL] [Abstract][Full Text] [Related]
13. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Qian XD; Beck WT Cancer Res; 1990 Feb; 50(4):1132-7. PubMed ID: 1967551 [TBL] [Abstract][Full Text] [Related]
14. B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein. Borchers C; Ulrich WR; Klemm K; Ise W; Gekeler V; Haas S; Schödl A; Conrad J; Przybylski M; Boer R Mol Pharmacol; 1995 Jul; 48(1):21-9. PubMed ID: 7623771 [TBL] [Abstract][Full Text] [Related]
15. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells. Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407 [TBL] [Abstract][Full Text] [Related]
16. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Lee CG; Gottesman MM; Cardarelli CO; Ramachandra M; Jeang KT; Ambudkar SV; Pastan I; Dey S Biochemistry; 1998 Mar; 37(11):3594-601. PubMed ID: 9530286 [TBL] [Abstract][Full Text] [Related]
17. Techniques to reverse or circumvent drug-resistance in vitro. Kuwano M; Nakagawa M; Shiraishi N; Yamaguchi T; Kikuchi J; Akiyama S Prog Clin Biol Res; 1986; 223():163-71. PubMed ID: 3809198 [TBL] [Abstract][Full Text] [Related]
18. Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Shudo N; Mizoguchi T; Kiyosue T; Arita M; Yoshimura A; Seto K; Sakoda R; Akiyama S Cancer Res; 1990 May; 50(10):3055-61. PubMed ID: 1970752 [TBL] [Abstract][Full Text] [Related]
19. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822 [TBL] [Abstract][Full Text] [Related]
20. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives. Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]